Aion Therapeutic Overview
- Year Founded
-
2011
- Status
-
Public
- Stock Symbol
-
ANTCF
- Investments
-
2
Aion Therapeutic General Information
Description
Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery. During the year ended the Company had one operating segment, being health and wellness, dedicated to delivering state-of-the-art water filtration solutions. Geographically company earns revenue from USA.
Contact Information
Website
aion-therapeutic.netlify.appCorporate Office
- 45 Sheppard Avenue East
- Suite 703
- Toronto, Ontario M2N 5W9
- Canada
Corporate Office
- 45 Sheppard Avenue East
- Suite 703
- Toronto, Ontario M2N 5W9
- Canada
Aion Therapeutic Timeline
Aion Therapeutic Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| 21.3K | -$0.01 |
Aion Therapeutic Financials Summary
As of 31-Jan-2025, Aion Therapeutic has a trailing 12-month revenue of $1.07M.
|
In Thousands, USD |
TTM 31-Jan-2025 | FY 2024 30-Apr-2024 | FY 2023 30-Apr-2023 | FY 2022 30-Apr-2022 |
|---|---|---|---|---|
| EV | 5,091 | 7,280 | 1,784 | 2,718 |
| Revenue | 1,067 | 272 | 0 | 0 |
| EBITDA | (4,489) | (4,508) | (67) | (2,930) |
| Net Income | (4,815) | (4,655) | (193) | (3,042) |
| Total Assets | 832 | 514 | 154 | 116 |
| Total Debt | 1,938 | 1,523 | 710 | 523 |
Aion Therapeutic Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Aion Therapeutic Patents
Aion Therapeutic Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022165439-A1 | Methods for treatment of human cancers using cannabis compositions | Inactive | 01-Feb-2021 |
Aion Therapeutic Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Aion Therapeutic Acquisitions (2)
Aion Therapeutic’s most recent deal was a Merger/Acquisition with Toppen Health for . The deal was made on 15-Dec-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Toppen Health | 15-Dec-2023 | Merger/Acquisition | Specialty Chemicals | ||
| AI Pharmaceuticals Jamaica | 30-Jun-2020 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology |
Aion Therapeutic ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Services
Subindustry
Rank
Percentile
Aion Therapeutic FAQs
-
When was Aion Therapeutic founded?
Aion Therapeutic was founded in 2011.
-
Where is Aion Therapeutic headquartered?
Aion Therapeutic is headquartered in Toronto, Canada.
-
What industry is Aion Therapeutic in?
Aion Therapeutic’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Aion Therapeutic a private or public company?
Aion Therapeutic is a Public company.
-
What is Aion Therapeutic’s stock symbol?
The ticker symbol for Aion Therapeutic is ANTCF.
-
What is Aion Therapeutic’s current revenue?
The trailing twelve month revenue for Aion Therapeutic is $1.07M.
-
What is Aion Therapeutic’s annual earnings per share (EPS)?
Aion Therapeutic’s EPS for 12 months was -$0.01.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process